In presenting this award, Frost & Sullivan commends the company's unique brand strategies and its successful foray into the medical device market, with products like the RTX3370 Telehealth Monitor that collects vital signs and subjective patient information from patient questionnaires and sends the data directly to the client's own Clinical Information System.
"With its decision to enter the medical market, RTX has demonstrated its interest in developing unique brands," notes Frost & Sullivan research analyst Ms C.R. Hema Varshika. "Moreover, the company's vast experience in establishing telehealth connections will give it significant advantages when selecting and designing device components and manufacturing strategies."
In 2001, with the strategic acquisition of Penell A/S, RTX acquired the necessary expertise to enter the healthcare market, and the company was introduced as RTX Healthcare A/S. Presently, the company has a dominant presence in the European market and a strong foothold in Denmark. RTX has also marked its presence in countries such as the United States and Hong Kong.
RTX works on several international standards such as VoIP, Bluetooth, GSM and DECT. "This has enabled RTX to gain an in-depth understanding of how these technologies function and their applications in different sectors," explains Ms Varshika. "Accordingly, the company has established itself in varied sectors, including healthcare and wireless technologies, among others."
RTX's product portfolio comprises an extensive range of products and services, such as design services, OEM products and technology licensing.
In the healthcare sector, RTX Healthcare recently introduced the RTX3370 Telehealth Monitor. This wireless device is designed specifically to improve the provision of healthcare to patients outside hospitals suffering from chronic diseases.
"The current portfolio also includes the development and manufacture of OEM/ODM products for remote patient monitoring," states Ms Varshika. "With RTX Healthcare's emphasis on remote patient monitoring, its perception of the growth potential of current and future markets is clear."
RTX Healthcare's wide customer clientele includes companies such as Alere Medical, Transoma Medical, Nonin Medical and Uno Medical. In addition to RTX Healthcare's understanding of customer needs, the company focuses on technologically advanced, high-quality products for accurate diagnosis and display of parameters. RTX Healthcare also ensures compliance with the extremely high regulatory standards set by healthcare regulatory authorities.
RTX attends various trade shows and exhibitions, enabling it to acquire better insight into market competition, while constantly expanding its customer base. Its innovative strategies to enter new markets, while increasing penetration in existing markets and its focus on customer satisfaction, have contributed to its success.
The Frost & Sullivan Award for Brand Development Strategy Leadership is presented to the company that has demonstrated excellence in brand development within the industry. The award recognizes RTX Healthcare's ability to best perceive customer needs, and to develop marketing strategies that elevate the brand's quality, style, and image to create an overall value perception. Through a combination of unique product quality, communication, distribution, and packaging strategies, the award recipient has demonstrated superior market growth skills.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.
About RTX Healthcare A/S
RTX Healthcare (rtx.dk) focuses on helping people suffering from chronic diseases to live a better and longer life with their disease. RTX Healthcare specializes in the development and manufacture of wireless medical devices for remote monitoring. It is RTX Healthcare's vision is to be known and recognized as a market leader in the healthcare industry at delivering the most appropriate and cost-effective telehealth solutions.
RTX Healthcare is a division of RTX Telecom A/S, which is an internationally oriented group with the goal of being the preferred partner for the development and production of advanced wireless communication IP and solutions. The company is based in Denmark with offices in California, Romania and Hong Kong. RTX Telecom A/S is listed on the Copenhagen Stock Exchange (OMX).
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
Add. Media Contact:
RTX, Communications Manager